TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors - Tagawa, ST; Balar, AV; Petrylak, DP (Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 2021)
et al.